#Hyperphagia, an insatiable hunger, is more than just an appetite—it's a challenge faced by individuals with rare #MC4R pathway diseases, often leading to severe obesity from an early age. Raising awareness is the first step toward understanding and supporting individuals living with these challenges. Together, we can bring cures closer to #MENAT patients. #RaisingAwareness #MC4RPathway
Genpharm’s Post
More Relevant Posts
-
Digital Media Transformation, Podcaster, Healthcare Advocate, Medical Communications, Patient Advocacy
It’s increasingly clear now that a regular update and in some cases a rewrite of guidelines need to be done. Newer tools, tech and specialities are available to help #healthcare innovate & improve how to treat #patients. Here’s one for clinicians.
It's here! The KDIGO 2024 CKD Guideline Executive Summary was released today in the April Issue of Kidney International (KI). Read the Executive Summary in KI: https://lnkd.in/grYUb6mu Download the PDF: https://lnkd.in/g9-UEiMX The KDIGO 2024 CKD Guideline, based on the best current evidence, indicates exciting new approaches to management strategies and treatment options for people living with #CKD. The goal is to improve symptom management, disease modification, and person-centered approaches while also recognizing the heterogeneity of CKD. The fact that new therapies exist and others are being evaluated heralds an exciting time for people living with #kidney diseases.
-
-
🌟 Exciting News in Kidney Disease Management! 🌟 📚 Just Released: A Comprehensive Guidance Document on Chronic Kidney Disease (CKD) Management 🔍 Multinational population studies based on CKD-PC 2023 analyses highlight the incremental increase in the association of all CKD complications with worse categories of estimated glomerular filtration rate (eGFR) and albuminuria. 💡 Key Highlights: -Emphasis on the importance of detecting CKD early, especially in high-risk populations. -Recommendations for accurate assessment of GFR and urine albumin-to-creatinine ratio (ACR). -Importance of using validated risk equations to estimate absolute risk of kidney failure. -Comprehensive discussion on delaying CKD progression and managing complications. -Insights into cardiovascular risk factor modification and drug stewardship in CKD. -Optimal models of care, including the value of multidisciplinary teams and advanced care planning. 🔬 Newer data on treating hyperuricemia were evaluated, with no support for targeting hyperuricemia in the absence of symptoms. 📊 Tables provided for "expected" values for common laboratory tests by eGFR to aid in identifying aberrant values. 🚀 Conclusion: This guidance document offers exciting new approaches to CKD management, aiming to improve symptom management, disease modification, and person-centered care. #KidneyDisease #CKDManagement #Healthcare #MedicalResearch #PatientCare #HealthTech #Nephrology #ChronicDiseaseManagement
It's here! The KDIGO 2024 CKD Guideline Executive Summary was released today in the April Issue of Kidney International (KI). Read the Executive Summary in KI: https://lnkd.in/grYUb6mu Download the PDF: https://lnkd.in/g9-UEiMX The KDIGO 2024 CKD Guideline, based on the best current evidence, indicates exciting new approaches to management strategies and treatment options for people living with #CKD. The goal is to improve symptom management, disease modification, and person-centered approaches while also recognizing the heterogeneity of CKD. The fact that new therapies exist and others are being evaluated heralds an exciting time for people living with #kidney diseases.
-
-
It's here! The KDIGO 2024 CKD Guideline Executive Summary was released today in the April Issue of Kidney International (KI). Read the Executive Summary in KI: https://lnkd.in/grYUb6mu Download the PDF: https://lnkd.in/g9-UEiMX The KDIGO 2024 CKD Guideline, based on the best current evidence, indicates exciting new approaches to management strategies and treatment options for people living with #CKD. The goal is to improve symptom management, disease modification, and person-centered approaches while also recognizing the heterogeneity of CKD. The fact that new therapies exist and others are being evaluated heralds an exciting time for people living with #kidney diseases.
-
-
The KDIGO 2024 CKD Guidelines are here! This is a major update to the 2012 guidelines which have guided CKD management for many years. Great job KDIGO on synthesizing the latest evidence to guide nephrologists in CKD care!
It's here! The KDIGO 2024 CKD Guideline Executive Summary was released today in the April Issue of Kidney International (KI). Read the Executive Summary in KI: https://lnkd.in/grYUb6mu Download the PDF: https://lnkd.in/g9-UEiMX The KDIGO 2024 CKD Guideline, based on the best current evidence, indicates exciting new approaches to management strategies and treatment options for people living with #CKD. The goal is to improve symptom management, disease modification, and person-centered approaches while also recognizing the heterogeneity of CKD. The fact that new therapies exist and others are being evaluated heralds an exciting time for people living with #kidney diseases.
-
-
The KDIGO 2024 CKD Guidebline Executive Summary.
It's here! The KDIGO 2024 CKD Guideline Executive Summary was released today in the April Issue of Kidney International (KI). Read the Executive Summary in KI: https://lnkd.in/grYUb6mu Download the PDF: https://lnkd.in/g9-UEiMX The KDIGO 2024 CKD Guideline, based on the best current evidence, indicates exciting new approaches to management strategies and treatment options for people living with #CKD. The goal is to improve symptom management, disease modification, and person-centered approaches while also recognizing the heterogeneity of CKD. The fact that new therapies exist and others are being evaluated heralds an exciting time for people living with #kidney diseases.
-
-
July is #GravesDiseaseAwarenessMonth. Thyroid Eye Disease (TED) is a prevalent comorbidity of Graves' Disease and can significantly impact a patient’s quality of life due to visual impairment and pain. The Endocrine Society shares insight into why individuals with #GravesDisease are prone to developing TED here. https://lnkd.in/gSy3gKJw
-
-
Every step counts in the fight against autoimmune blistering diseases! 🌟 From enlightening talks and personal stories to interactive sessions and heartfelt connections, we came together to spread knowledge about autoimmune blistering diseases and to support one another in this journey. 💬 Your presence and involvement mean the world to us and bring us one step closer to a future where no one has to face these challenges alone. 🌍🤝 Let's continue to raise awareness, advocate for better treatments, and support each other with strength and compassion. 💪💜 Visit www.aibdf.in for more information! 🌐 #aibdf #autoimmuneblisteringdiseases #autoimmunedisorder #blister #autoimmunelife #autoimmunewarriors #discussion #autoimmunewarrior #autoimmunedisease #autoimmunediseaseawareness #autoimmunecondition #supportgroup #autoimmunehealth #autoimmunedisorders #autoimmunediseases #autoimmuneawareness #blisters #autoimmuneillness #patientcare #autoimmunefighter
-
Proclaimed in 1998 by the Global Initiative for Asthma, 𝗪𝗼𝗿𝗹𝗱 𝗔𝘀𝘁𝗵𝗺𝗮 𝗗𝗮𝘆 commemorates the more than 260 million people affected by one of the most widespread chronic diseases in the world. 🩺 This year's theme "𝗔𝘀𝘁𝗵𝗺𝗮 𝗘𝗱𝘂𝗰𝗮𝘁𝗶𝗼𝗻 𝗘𝗺𝗽𝗼𝘄𝗲𝗿𝘀" emphasizes the importance of professional treatment of lung diseases, as around 450,000 people die of it every year - most of these deaths are preventable. 🫁 Clinical studies pave the way for enhanced understanding and effective management of chronic lung conditions like #asthma, thereby fostering successful treatment outcomes. #WorldAsthmaDay #AsthmaEducationEmpowers #ClinicalStudies #MedicalResearch
-
-
On the occasion of World Vitiligo Day, let's shed light on vitiligo and spread awareness! Vitiligo, also known as the white spot disease, affects about 1% of the world's population. It's a condition where pigment cells in the skin are lost, leading to distinct white patches. Regular health check-ups are recommended for individuals with vitiligo to monitor and manage any associated autoimmune conditions such as diabetes and thyroid disorders. #CitizensSpecialtyHospital #multispecialityhospital #WorldVitiligoDay #Vitiligo
-
